Level 2

Company Announcements

Holding(s) in Company

Related Companies

RNS Number : 2738G
Ark Therapeutics Group PLC
02 March 2015
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

Ark Therapeutics Group Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights

YES

Other (please specify):



3. Full name of person(s) subject to the
notification obligation:
iii

J O HAMBRO CAPITAL MANAGEMENT LIMITED

4. Full name of shareholder(s)
 (if different from 3.):iv


5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

27 FEBRUARY 2015

6. Date on which issuer notified:

02 MARCH 2015

7. Threshold(s) that is/are crossed or
reached:
vi, vii

BELOW 5%



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00BSZLMS59

206594

206594

166007

166007


1.19%



B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







Total (A+B)

Number of voting rights

Percentage of voting rights

166007

1.19%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

 

NOT APPLICABLE


Proxy Voting:

10. Name of the proxy holder:

-

11. Number of voting rights proxy holder will cease
to hold:

-

12. Date on which proxy holder will cease to hold
voting rights:

-



13. Additional information:

-

14. Contact name:

F Nicolaou

15. Contact telephone number:

0207 747 8971

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFMGGFDZDGKZM

Top of Page